申请人:VALORISATION-RECHERCHE, LIMITED PARTNERSHIP
公开号:US20190202863A1
公开(公告)日:2019-07-04
Novel cyclic peptide GHRP-6 analogs of formula (I): (I) or pharmaceutically acceptable esters or salts thereof, are described. These cyclic peptide GHRP-6 analogs may be used for modulating CD36 activity, for example for the treatment of CD36-related diseases, disorders or conditions in a subject, such as atherosclerosis and age-related macular degeneration.